Sage Journals: Discover world-class research

Retricted access

Review article

First published 2021-11

Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets

Valerio Caputo, Claudia Strafella, Andrea Termine [...]

European Journal of Ophthalmology

Open access

Review article

First published 2020

Current and Future Treatments in Alzheimer Disease: An Update

Konstantina G Yiannopoulou, Sokratis G Papageorgiou

Journal of Central Nervous System Disease

Free access

Review article

First published 2013-1

Current and future treatments for Alzheimer’s disease

Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2016-02

Enhancing Therapeutic Efficacy and Reducing Cell Dosage in Stem Cell Transplantation Therapy for Ischemic Limb Diseases by Modifying the Cell Injection Site

Jung-Youn Shin, Jeong-Kee Yoon, Myung Kyung Noh [...]

Tissue Engineering Part A: Research Advances

Open access

Review article

First published 2026

Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease

Tom Foltynie, Sonia Gandhi, Camille Carroll

Journal of Parkinson’s Disease

Open access

Research article

First published 2021

Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer’s disease therapeutic

Min Su Kang, Monica Shin, Julie Ottoy [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted access

Case report

First published 2016-7

Use of a Cholestyramine Washout in a Patient With Septic Shock on Leflunomide Therapy

Melissa Laub, Robert Fraser, Jonathan Kurche [...]

Journal of Intensive Care Medicine

Open access

Research article

First published 2018

An epidemiological study on the course of disease and therapeutic considerations in relapsing–remitting multiple sclerosis patients receiving injectable first-line disease-modifying therapies in Germany (EPIDEM)

Stephan Schmidt, Jürgen Koehler, Christine Winterstein [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Review article

First published 2017-9-15

Post-Translational Oxidative Modifications of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase): Implications for Pathogenesis and Therapeutics in Human Diseases

M.M. Srinivas Bharath

Journal of Alzheimer’s Disease

Retricted access

Letter

First published 2014-12

Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?

Mario Rotondi, Roberto Bergamaschi, Luca Chiovato

Multiple Sclerosis Journal

Search results